We are live on ! Find out more
SCM

Shelton Capital Management Portfolio holdings

AUM $4.57B
1-Year Est. Return 32.26%
This Fund
S&P 500
This Quarter Est. Return
+10.16%
1 Year Est. Return
+32.26%
3 Year Est. Return
+110.31%
5 Year Est. Return
+153.06%
10 Year Est. Return
+630.09%
AUM
$661M
AUM Growth
+$63.6M
Cap. Flow
+$8.57M
Cap. Flow %
1.3%
Top 10 Hldgs %
16.59%
Holding
777
New
87
Increased
152
Reduced
160
Closed
27

Top Buys

Rank Stock Value
1
AX icon
Axos Financial
AX
+$1.14M
2
ICE icon
Intercontinental Exchange
ICE
+$1.1M
3
EXEL icon
Exelixis
EXEL
+$1.1M
4
TSLA icon
Tesla
TSLA
+$1.09M
5
INTC icon
Intel
INTC
+$582K

Top Sells

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$3.57M
2
FLG
Flagstar Bank National Association
FLG
+$1.62M
3
CELG
Celgene Corp
CELG
+$1.59M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$1.54M
5
AME icon
Ametek
AME
+$1.25M

Sector Composition

Rank Sector Weight
1 Technology 17.89%
2 Healthcare 15%
3 Financials 12.41%
4 Industrials 10.23%
5 Energy 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WAB icon
176
Wabtec
WAB
$50.1B
$795K 0.12%
10,710
– –
JBHT icon
177
JB Hunt Transport Services
JBHT
$25.9B
$785K 0.12%
10,154
– –
EZCH
178
DELISTED
EZCHIP SEMICONDUCTOR LIMITED ORD SHS (IL)
EZCH
$775K 0.12%
31,500
+1,500
+5% +$37K
AOS icon
179
A.O. Smith
AOS
$8.51B
$774K 0.12%
28,694
+17,646
+160% +$452K
HBI
180
DELISTED
Hanesbrands
HBI
$772K 0.12%
43,964
– –
FNF icon
181
Fidelity National Financial
FNF
$12.7B
$769K 0.12%
41,516
– –
PBR icon
182
Petrobras
PBR
$116B
$765K 0.12%
55,500
-3,400
-6% -$52.7K
ASH icon
183
Ashland
ASH
$3.4B
$764K 0.12%
16,094
-695
-4% -$31.1K
PCG icon
184
PG&E
PCG
$38.1B
$758K 0.11%
18,830
+1,000
+6% +$41K
FLR icon
185
Fluor
FLR
$7.11B
$749K 0.11%
9,330
+2,800
+43% +$214K
Y
186
DELISTED
Alleghany Corp
Y
$749K 0.11%
1,872
– –
EPC icon
187
Edgewell Personal Care
EPC
$1.31B
$745K 0.11%
9,287
– –
ALXN
188
DELISTED
Alexion Pharmaceuticals
ALXN
$744K 0.11%
5,592
+726
+15% +$87.1K
OGE icon
189
OGE Energy
OGE
$9.68B
$736K 0.11%
21,712
-388
-2% -$13.9K
REGN icon
190
Regeneron Pharmaceuticals
REGN
$82B
$736K 0.11%
2,675
+114
+4% +$32.8K
MAN icon
191
ManpowerGroup
MAN
$2.6B
$734K 0.11%
8,549
– –
RMD icon
192
ResMed
RMD
$32.7B
$732K 0.11%
15,549
-386
-2% -$19.5K
IT icon
193
Gartner
IT
$11.4B
$729K 0.11%
10,261
– –
FRT icon
194
Federal Realty Investment Trust
FRT
$10.2B
$728K 0.11%
7,174
– –
UAA icon
195
Under Armour
UAA
$2.26B
$723K 0.11%
33,128
– –
A icon
196
Agilent Technologies
A
$41.8B
$715K 0.11%
17,479
– –
FSLR icon
197
First Solar
FSLR
$24.4B
$709K 0.11%
12,970
– –
UNFI icon
198
United Natural Foods
UNFI
$2.91B
$703K 0.11%
9,331
+1,661
+22% +$117K
FCX icon
199
Freeport-McMoran
FCX
$96.2B
$701K 0.11%
18,574
+98
+0.5% +$3.47K
SI
200
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
$697K 0.11%
5,035
-3,500
-41% -$451K
6 7
8
9 10

Similar funds

SV
Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
JRP
Jasper Ridge Partners Menlo Park, California $4.49B AUM 18.72% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return
GIBU
Gulf International Bank (UK) London, United Kingdom $4.47B AUM 29.35% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM

Shelton Capital Management's Q4 2013 Portfolio in Review

As of Q4 2013, Shelton Capital Management held 777 positions worth $661M, up 11% from $598M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Shelton Capital Management's Q4 2013 filing shows 87 new, 152 increased, 160 reduced and 27 closed positions. Its largest new stake was Axos Financial: 63,596 shares worth $1.25M. The largest sale was BioMarin Pharmaceuticals, an estimated $3.57M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • Shelton Capital Management's largest Q4 2013 buy was Axos Financial: 63,596 shares worth $1.25M.
  • Shelton Capital Management added most to Tesla in Q4 2013, an estimated $1.09M increase.
  • Shelton Capital Management's biggest Q4 2013 reduction was BioMarin Pharmaceuticals, cutting an estimated $3.57M.
  • Shelton Capital Management fully exited Ametek in Q4 2013, selling an estimated $1.25M.
  • Shelton Capital Management's ten largest holdings make up 17% of its $661M portfolio in Q4 2013.
  • Shelton Capital Management opened 87 new positions and closed 27 in Q4 2013.
  • Shelton Capital Management's portfolio value rose 11% quarter-over-quarter to $661M.

Based on Shelton Capital Management's 13F filing for Q4 2013, filed 22 Jan 2014.